From Buffy Coat Platelets to Single Donor Platelets – A Feasibility Study Dr. Sybesma, Sanquin...
-
Upload
heidi-molenaar -
Category
Documents
-
view
217 -
download
3
Transcript of From Buffy Coat Platelets to Single Donor Platelets – A Feasibility Study Dr. Sybesma, Sanquin...
![Page 1: From Buffy Coat Platelets to Single Donor Platelets – A Feasibility Study Dr. Sybesma, Sanquin Bloodbank Southeast, ‘s-Hertogenbosch, Netherlands St. Petersburg.](https://reader035.fdocuments.in/reader035/viewer/2022070315/5551a0f04979591f3c8bacc3/html5/thumbnails/1.jpg)
From Buffy Coat Platelets to Single Donor Platelets – A
Feasibility Study
Dr. Sybesma, Sanquin Bloodbank Southeast,
‘s-Hertogenbosch, Netherlands
St. Petersburg - June 9th - 2004
![Page 2: From Buffy Coat Platelets to Single Donor Platelets – A Feasibility Study Dr. Sybesma, Sanquin Bloodbank Southeast, ‘s-Hertogenbosch, Netherlands St. Petersburg.](https://reader035.fdocuments.in/reader035/viewer/2022070315/5551a0f04979591f3c8bacc3/html5/thumbnails/2.jpg)
Improvement of transfusion safety by reduction of donor exposure
• Variant Creutzfeldt-Jakob disease (Houston et al. 2000)
• Septic platelet transfusion reactions (Ness et al. 2001)
• Residual risk of viral infection (Soldan et al. 2003, Jackson et al. 2003)
• HLA - (Slichter 1998) and HPA - refractoriness
• TRALI
• Unknown agents
![Page 3: From Buffy Coat Platelets to Single Donor Platelets – A Feasibility Study Dr. Sybesma, Sanquin Bloodbank Southeast, ‘s-Hertogenbosch, Netherlands St. Petersburg.](https://reader035.fdocuments.in/reader035/viewer/2022070315/5551a0f04979591f3c8bacc3/html5/thumbnails/3.jpg)
Donors and methods
Technical:donors selection: precount > 250, 70 kg
Trima Accel, 100 procedures
procedure time 70’
QC, splitting > 500
Economical:434 Euro* pooled and single donor
Logistical:autosufficient 2500 PLT per year
* nov 2002
![Page 4: From Buffy Coat Platelets to Single Donor Platelets – A Feasibility Study Dr. Sybesma, Sanquin Bloodbank Southeast, ‘s-Hertogenbosch, Netherlands St. Petersburg.](https://reader035.fdocuments.in/reader035/viewer/2022070315/5551a0f04979591f3c8bacc3/html5/thumbnails/4.jpg)
TRIMA Accel
![Page 5: From Buffy Coat Platelets to Single Donor Platelets – A Feasibility Study Dr. Sybesma, Sanquin Bloodbank Southeast, ‘s-Hertogenbosch, Netherlands St. Petersburg.](https://reader035.fdocuments.in/reader035/viewer/2022070315/5551a0f04979591f3c8bacc3/html5/thumbnails/5.jpg)
Donorselection
Distribution (%) of donors (n=105) by PLT precount and weight
5824
18
> 250 and > 70 kg
225 - 250 and 63-70 kg
< 225 and < 63 kg
![Page 6: From Buffy Coat Platelets to Single Donor Platelets – A Feasibility Study Dr. Sybesma, Sanquin Bloodbank Southeast, ‘s-Hertogenbosch, Netherlands St. Petersburg.](https://reader035.fdocuments.in/reader035/viewer/2022070315/5551a0f04979591f3c8bacc3/html5/thumbnails/6.jpg)
Number procedures per procedure time
69
23
8
0
10
20
30
40
50
60
70
80
< 70 min 70 - 90 min > 90 min
procedure time
number proce-dures
![Page 7: From Buffy Coat Platelets to Single Donor Platelets – A Feasibility Study Dr. Sybesma, Sanquin Bloodbank Southeast, ‘s-Hertogenbosch, Netherlands St. Petersburg.](https://reader035.fdocuments.in/reader035/viewer/2022070315/5551a0f04979591f3c8bacc3/html5/thumbnails/7.jpg)
Donor reactions
Form
289 procedures:
Citrate reactions:
Mild: 37,
Moderate: 1,
Severe: 0
Collaps: 0
Haematoma: 5
Hyperventilation: 0
![Page 8: From Buffy Coat Platelets to Single Donor Platelets – A Feasibility Study Dr. Sybesma, Sanquin Bloodbank Southeast, ‘s-Hertogenbosch, Netherlands St. Petersburg.](https://reader035.fdocuments.in/reader035/viewer/2022070315/5551a0f04979591f3c8bacc3/html5/thumbnails/8.jpg)
Evolution - Real/Target Yield
0,8
0,82
0,84
0,86
0,88
0,9
0,92
0,94
0,96
1-50 51-100 101-150 151-200 200-245
Chronological groups of procedures
Real Y
ield
/Targ
et
Yie
ld
![Page 9: From Buffy Coat Platelets to Single Donor Platelets – A Feasibility Study Dr. Sybesma, Sanquin Bloodbank Southeast, ‘s-Hertogenbosch, Netherlands St. Petersburg.](https://reader035.fdocuments.in/reader035/viewer/2022070315/5551a0f04979591f3c8bacc3/html5/thumbnails/9.jpg)
Evolution of split-rate (>500x10e9)
0,50,550,6
0,650,7
0,750,8
0,850,9
1-50 51-100 101-150 151-200 201-246
chronological groups procedures
% s
plt-r
ate
![Page 10: From Buffy Coat Platelets to Single Donor Platelets – A Feasibility Study Dr. Sybesma, Sanquin Bloodbank Southeast, ‘s-Hertogenbosch, Netherlands St. Petersburg.](https://reader035.fdocuments.in/reader035/viewer/2022070315/5551a0f04979591f3c8bacc3/html5/thumbnails/10.jpg)
Chronological trending of residual WBC levels
Residual WBC levels All Product
0
0.5
1
1.5
2
2.5
3
1 8
15
22
29
36
43
50
57
64
71
78
85
92
99
10
6
11
3
12
0
Sequence number
WB
Cx
10
E6
/Un
it
Series1
![Page 11: From Buffy Coat Platelets to Single Donor Platelets – A Feasibility Study Dr. Sybesma, Sanquin Bloodbank Southeast, ‘s-Hertogenbosch, Netherlands St. Petersburg.](https://reader035.fdocuments.in/reader035/viewer/2022070315/5551a0f04979591f3c8bacc3/html5/thumbnails/11.jpg)
Logistical feasibility
TRIMA: 6 procedures per day
50 weeks
190 donors
8 donations per year*
2600 SDP per year
18 % drop-out by out-dating
* Lazarus et al. 2001
![Page 12: From Buffy Coat Platelets to Single Donor Platelets – A Feasibility Study Dr. Sybesma, Sanquin Bloodbank Southeast, ‘s-Hertogenbosch, Netherlands St. Petersburg.](https://reader035.fdocuments.in/reader035/viewer/2022070315/5551a0f04979591f3c8bacc3/html5/thumbnails/12.jpg)
Donor satisfaction
![Page 13: From Buffy Coat Platelets to Single Donor Platelets – A Feasibility Study Dr. Sybesma, Sanquin Bloodbank Southeast, ‘s-Hertogenbosch, Netherlands St. Petersburg.](https://reader035.fdocuments.in/reader035/viewer/2022070315/5551a0f04979591f3c8bacc3/html5/thumbnails/13.jpg)
Economical feasibility
Cost price for SDP are less than revenues
High split rates are beneficial for economical feasibility
Revenues for SDP are higher than for BCP
Cost of SDP are higher than for BCP
Distribution of secondary costs over different components influence the cost of BCP
![Page 14: From Buffy Coat Platelets to Single Donor Platelets – A Feasibility Study Dr. Sybesma, Sanquin Bloodbank Southeast, ‘s-Hertogenbosch, Netherlands St. Petersburg.](https://reader035.fdocuments.in/reader035/viewer/2022070315/5551a0f04979591f3c8bacc3/html5/thumbnails/14.jpg)
Conclusions Conversion is feasible economically, technically and logistically.
Adequate donor selection + high collection performence assure high split-rates in relatively short procedure time.
further research is needed on:
how to keep donormotivation at high level
donor recruitment and donor selection
possibilities to reduce drop-out by outdating
Cost / Qualy’s for pooled and apheresis PLT should be analyzed